Darius Kharabi
Corporate Officer/Principal chez KALA BIO, INC.
Fortune : 116 928 $ au 31/03/2024
Profil
Darius Kharabi is a co-founder of Lagunita and is co-founder, President & CEO of Combangio.
He is a Board member of Combangio and Kedalion Therapeutics.
Mr. Kharabi focuses on company creation at Lagunita and previously served as executive management for xCella and Kedalion, helping to build early value, raise financing and recruit full-time leadership teams.
Prior to Lagunita, he served as Vice President, Corporate Development and International Sales at OrthAlign Inc., a commercial stage orthopedic surgery navigation company, where his responsibilities included the launch of the KneeAlign® total knee arthroplasty navigation product line in North America, Europe, Asia and Australia.
Mr. Kharabi started his career as a biotechnology licensing attorney at Wilson, Sonsini Goodrich & Rosati PC.
He received his B.S.
in Biochemistry from Georgetown University and his J.D.
and M.B.A.
degrees from Stanford University
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
KALA BIO, INC.
0,54% | 04/01/2024 | 14 671 ( 0,54% ) | 116 928 $ | 31/03/2024 |
Postes actifs de Darius Kharabi
| Sociétés | Poste | Début |
|---|---|---|
| KALA BIO, INC. | Corporate Officer/Principal | 15/11/2021 |
Kedalion Therapeutics, Inc.
 Kedalion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Kedalion Therapeutics, Inc. operates as a clinical-stage biotechnology company. It focuses on the development and commercialization of topical ophthalmology therapies based on its proprietary AcuStream platform. The company was founded by Mark Blumenkranz and Ehud Ivri and is headquartered in Menlo Park, CA. | Director/Board Member | 01/11/2017 |
xCella Biosciences, Inc.
 xCella Biosciences, Inc. Pharmaceuticals: MajorHealth Technology xCella Biosciences, Inc. engages in the development of protein therapeutics for cancer treatment. Its pipeline is XC-201, a tumor targeting agent. The company was founded by Bob Chen and K. Dane Wittrup and is headquartered in Menlo Park, CA. | Chief Executive Officer | 01/08/2019 |
Lagunita Biosciences LLC
 Lagunita Biosciences LLC Investment ManagersFinance Lagunita Biosciences LLC (Lagunita Biosciences) is a venture Capital firm founded in 2015 by Mark S. Blumenkranz. The firm is headquartered in Menlo Park, California. | Founder | - |
Anciens postes connus de Darius Kharabi
| Sociétés | Poste | Fin |
|---|---|---|
Combangio, Inc.
 Combangio, Inc. Miscellaneous Commercial ServicesCommercial Services Combangio, Inc. operates as an investment holding company. The company was headquartered in Menlo Park, CA. | Chief Executive Officer | 01/12/2021 |
OrthAlign Corp.
 OrthAlign Corp. Medical SpecialtiesHealth Technology OrthAlign Corp. engages in the provision of precision alignment technology and products. It offers orthopedic services. The company was founded by Pieter Wolters and Curt Stone in 2008 and is headquartered in Aliso Viejo, CA. | Corporate Officer/Principal | - |
Formation de Darius Kharabi
| Stanford University | Graduate Degree |
| Georgetown University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| KALA BIO, INC. | Health Technology |
| Entreprise privées | 5 |
|---|---|
OrthAlign Corp.
OrthAlign Corp. Medical SpecialtiesHealth Technology OrthAlign Corp. engages in the provision of precision alignment technology and products. It offers orthopedic services. The company was founded by Pieter Wolters and Curt Stone in 2008 and is headquartered in Aliso Viejo, CA. | Health Technology |
Lagunita Biosciences LLC
Lagunita Biosciences LLC Investment ManagersFinance Lagunita Biosciences LLC (Lagunita Biosciences) is a venture Capital firm founded in 2015 by Mark S. Blumenkranz. The firm is headquartered in Menlo Park, California. | Finance |
Kedalion Therapeutics, Inc.
Kedalion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Kedalion Therapeutics, Inc. operates as a clinical-stage biotechnology company. It focuses on the development and commercialization of topical ophthalmology therapies based on its proprietary AcuStream platform. The company was founded by Mark Blumenkranz and Ehud Ivri and is headquartered in Menlo Park, CA. | Health Technology |
xCella Biosciences, Inc.
xCella Biosciences, Inc. Pharmaceuticals: MajorHealth Technology xCella Biosciences, Inc. engages in the development of protein therapeutics for cancer treatment. Its pipeline is XC-201, a tumor targeting agent. The company was founded by Bob Chen and K. Dane Wittrup and is headquartered in Menlo Park, CA. | Health Technology |
Combangio, Inc.
Combangio, Inc. Miscellaneous Commercial ServicesCommercial Services Combangio, Inc. operates as an investment holding company. The company was headquartered in Menlo Park, CA. | Commercial Services |
